Novasure
Device Surgical
PDI 15420045500853
General payments
$536,857
Research payments
$0
Through program year 2025, $536,857 in general payments and $0 in research payments were reported against Novasure (Surgical).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $219,410 | 3,937 |
| 2024 | General | $154,979 | 3,175 |
| 2023 | General | $64,946 | 1,588 |
| 2022 | General | $56,635 | 2,018 |
| 2021 | General | $40,887 | 1,012 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 56 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
11,730 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.